Prices delayed by at least 15 minutes | Print
Bio-Techne Corp (TECH)
Common SharesOpen
$70.54
Previous close
$63.21
Trade high
$76.68
Volume
3,117,232
Year high
$89.91
Year low
$51.79
Dividend yield
0.51%
Market capitalisation
$11.55 bn
P/E ratio
45.47
ISIN
US09073M1045
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Share price
Dividends
| Previous | Latest | |
|---|---|---|
| Record date | 12/02/2024 | 13/05/2024 |
| Ex-dividend date | 09/02/2024 | 10/05/2024 |
| Payment date | 26/02/2024 | 24/05/2024 |
| Amount | $0.08 | $0.08 |
Company profile
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%),with the rest of the world accounting for the remaining 5%.
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.